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Abstract  
Objective  
This cross-sectional study assessed the association of chronic physical conditions and 
multimorbidity with anxiety among community-dwelling adults in 42 countries. 
Method 
Data were analyzed from the World Health Survey including 181,845 adults aged ≥18 years. 
Anxiety in the past 30 days and nine chronic physical conditions (angina, arthritis, asthma, 
chronic back pain, diabetes, edentulism, hearing problem, tuberculosis, and visual 
impairment) were assessed. Multivariable logistic regression analyses were conducted to 
explore the associations between chronic physical conditions or the number of them and 
anxiety. 
Results 
After adjustment for confounders, most of the individual chronic physical conditions were 
significantly associated with anxiety. Compared to those with no physical health conditions, 
one condition was associated with an almost twofold increased odds of anxiety symptoms 
(OR=1.94; 95%CI=1.76-2.13), while this figure rose to 5.49 (3.73-8.09) in those with ≥5 
conditions.  
Conclusions 
Our data suggest that increasing numbers of chronic physical conditions are associated with 
higher odds for anxiety. Health care providers should consider the presence of anxiety 
symptoms especially in individuals with physical multimorbidity.  
 
Keywords: anxiety, multimorbidity, angina, asthma, back pain, arthritis 
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Introduction 
Anxiety is a common and disabling mental health condition [1]. It can greatly impair a 
person’s functioning, quality of life and well-being [2]. Anxiety is characterized by excessive 
and persistent (yet often unrealistic) worry which can inhibit one’s ability to carry out 
activities of daily living, and which, if left untreated can develop into an anxiety disorder [3]. 
In a systematic review of prevalence studies across 44 countries, the global point prevalence 
of anxiety disorders was estimated at 7.3% (95% confidence interval, CI=4.8-10.9), 
suggesting that one in 14 people around the world at any given time has an anxiety disorder, 
while roughly one in nine (11.6%, 95% CI=7.6-17.7) has an anxiety disorder in any given 
year [4]. Anxiety disorders are the sixth leading global cause of years lived with disability 
[5]. Moreover, the global financial burden of anxiety is substantial, owing to lost work 
productivity and high medical resource use [6, 7].   
There is growing recognition that numerous mental health conditions are associated 
with an increased physical health burden. For example, it is well established that anxiety is 
associated with several chronic physical co-morbidities [1]. Of particular concern are 
cardiovascular diseases [8], diabetes [9], pulmonary diseases [10], chronic pain [11], 
infectious diseases such as tuberculosis [12], arthritis [13], edentulism [14], and mainly in 
older people, visual impairment [15] and hearing problems [16]. Given the increasing 
prevalence of chronic conditions worldwide [17], a further understanding of the determinants, 
consequences and management of the comorbidity between anxiety and chronic physical 
conditions should be a research priority. Whilst progress has been made, most studies to date 
have however, examined the co-occurrence of anxiety with a single comorbid physical health 
condition. For example, in a recent cross-sectional household survey of community-dwelling 
adults conducted in 17 countries (47,609 participants) [18], 9 out of the 10 investigated 
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chronic physical health conditions (only the risk for cancer was not increased) were 
associated with higher odds for generalized anxiety disorder with odds ratios (OR) ranging 
from 1.3 (95% CI=1.0-1.6) for diabetes to 2.5 (95% CI=1.8-3.5) for a chronic lung disease.  
Whilst investigating single chronic conditions is important, there is increasing 
recognition that many people may have multiple comorbidities. Multimorbidity (i.e. the 
presence of multiple chronic conditions) is relatively common in the general population with 
reported prevalence figures as high as 72% [19]. The heightened prevalence of 
multimorbidity is mainly due to the growing incidence of chronic conditions [17] and 
increasing life-expectancies, and it is undoubtedly one of the most significant challenges 
faced by health care providers and governments across the globe [20, 21]. Multimorbidity is 
associated with a marked lower quality of life [22], increased health-care utilization [23], and 
ultimately, a higher risk for premature mortality [24]. Despite this, there is a paucity of 
studies on the associations between anxiety and multimorbidity. Only one population study to 
date among 4219 participants 65 years or older in the US [25] found that two and ≥ three 
medical conditions yielded a 1.96-fold (95% CI=1.13–3.41) and 3.49-fold (95% CI=2.05–
5.95) increased odds of elevated anxiety respectively, compared to those with no medical 
conditions. Whilst helpful, the relatively modest sample size, restriction to a single country 
and focus only on older adults, limits the generalizability of the findings. Thus, more research 
on the prevalence of anxiety in people with multimorbidity, in particular across increasing 
number of co-morbidities, is essential to identify high risk subgroups, which would 
preferentially benefit from tailored preventative and therapeutic strategies.  
To the best of our knowledge, there are no multinational representative population 
studies investigating associations between anxiety and multimorbidity. This is an important 
research gap, given the increasing prevalence of chronic physical health conditions globally, 
and especially in low- and middle-income countries [26]. Understanding associations 
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between multimorbidity and anxiety can inform the development of targeted interventions 
and policies. The aim of the current study therefore was to explore the association between 
anxiety, chronic conditions and multimorbidity across 42 countries from Africa, Asia, 
Europe, and Latin-America, and to assess whether the associations are similar across all 
countries. 
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Methods 
Procedure and settings 
The current paper utilized data from the World Health Survey (WHS), a cross-sectional study 
undertaken in 2002-2004 in 70 countries worldwide. Data were collected using single-stage 
random sampling and stratified multi-stage random cluster sampling across 10 and 60 
countries respectively. Full details of the WHS are freely available elsewhere 
(http://www.who.int/healthinfo/survey/en/). Briefly, persons aged ≥18 years with a valid 
home address were eligible to participate. Each member of the household had equal 
probability of being selected by utilizing Kish tables. A standardized questionnaire, translated 
accordingly, was used across all countries. The individual response rate (i.e. ratio of 
completed interviews among selected respondents after excluding ineligible respondents from 
the denominator) ranged from 63% (Israel) to 99% (Philippines) [27]. In order to conduct the 
study, ethical approval was obtained from the ethical boards at each study site. Sampling 
weights were generated to adjust for non-response and the population distribution reported by 
the United Nations Statistical Division. Informed consent was obtained from all participants. 
 
Anxiety (outcome variable) 
Anxiety was assessed by the question ‘Overall in the past 30 days, how much of a problem 
did you have with worry or anxiety’ with response alternatives: none, mild, moderate, severe, 
and extreme. In accordance with previous WHS publications, those who answered severe and 
extreme were considered to have anxiety [28, 29]. 
 
Chronic physical conditions and numbers of chronic physical conditions (exposure variables) 
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A total of nine physical conditions were assessed as part of the WHS. Arthritis, asthma, and 
diabetes were based on self-reported lifetime diagnosis. For angina, in addition to a self-
reported diagnosis, a symptom-based diagnosis based on the Rose questionnaire was also 
used [30]. Chronic back pain was defined as having had back pain (including disc problems) 
every day during the last 30 days. Visual impairment was defined as having extreme 
difficulty in seeing and recognizing a person that the participant knows across the road (i.e., 
from a distance about 20 meters) [31]. A validity study showed that this response likely 
corresponds to World Health Organization definitions of visual impairment [31]. The 
participant was considered to have hearing problems if the interviewer observed this 
condition at the end of the survey. Edentulism was assessed by the question “Have you lost 
all your natural teeth?” Those who responded affirmatively were considered to have 
edentulism. Finally, a tuberculosis diagnosis was based on past 12-month symptoms and was 
defined as: 1) having had a cough that lasted for three weeks or longer; and 2) having had 
blood in phlegm or coughed up blood [32]. We calculated the total number of these 
conditions while allowing for one missing variable in order to retain a larger sample size. The 
number of chronic physical conditions was categorized as 0, 1, 2, 3, 4, and ≥5. 
 
Co-variates 
The selection of the co-variates was based on past literature and included sex, age (18-34, 35-
59, ≥60), wealth, and depression [25]. Principal component analysis based on 15-20 assets 
was conducted to establish country-wise wealth quintiles. Past 12-month depression was 
defined using the DSM-IV algorithm using individual questions of the World Mental Health 
Survey version of the Mental Health Composite International Diagnostic Interview (CIDI) 
[33], and was based on duration and persistence of depressive symptoms in the past 12 
months using the same algorithms as previous WHS publications [34, 35]. Respondents were 
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first asked five questions. Those who answered ‘Yes’ to four of them were considered as 
possibly having depression or a major depressive episode. Specifically, respondents were 
asked: “During the last 12 months have you ever experienced…”: (a) A period lasting several 
days when you felt sad, empty or depressed? (b) A period lasting several days when you lost 
interest in most things you usually enjoy such as hobbies, personal relationships or work? (c) 
A period lasting several days when you have been feeling your energy level decreased or that 
you were tired all the time? (d) Did you lose your appetite? (e) Did you notice any slowing 
down in your thinking?’. Among those with possible depression, individuals who further 
responded ‘Yes’ to both of the following questions were classified as having depression: (a) 
Was this period for more than 2 weeks? (b) Was this period most of the day, nearly every 
day? 
 
Statistical analysis 
Of the 70 countries which participated in the WHS, 69 had data which is publically available. 
Ten countries (Austria, Belgium, Denmark, Germany, Greece, Guatemala, Italy, Netherlands, 
Slovenia, and UK) were excluded due to lack of data on sampling information. A further 9 
countries (Finland, France, Ireland, Israel, Luxembourg, Morocco, Norway, Portugal, 
Sweden) were deleted as data on anxiety and/or some of the chronic physical conditions were 
not collected. Turkey was also dropped due to a lack of information on depression. 
Furthermore, 5 countries (Congo, Mali, Mexico, Slovakia, Swaziland) with more than 25% of 
data on the number of chronic physical conditions and/or anxiety missing were also deleted. 
Finally, Kazakhstan and Sri Lanka were deleted due to their exceptionally high prevalence of 
anxiety (79.2% and 65.2% respectively). Thus, the final sample consisted of 42 countries 
(n=181,845). These data were nationally representative in all countries with the exception of 
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China, Comoros, Ivory Coast, India, and Russia where the study was conducted in 
geographically restricted areas. 
The statistical analysis was done with Stata 14.1 (Stata Corp LP, College station, 
Texas). Descriptive analyses were conducted to characterize the study sample. The difference 
in sample characteristics by the presence of anxiety was tested by Chi-squared tests. 
Tetrachoric correlations between each pair of physical health condition were calculated for 
those with anxiety. Using the sample including all countries, multivariable logistic regression 
analysis was performed to assess the associations of each chronic physical condition and 
number of chronic physical conditions (exposure variables) with anxiety (outcome variable). 
Separate models were constructed for each chronic physical condition and number of chronic 
physical conditions. Two models were constructed: Model 1 - adjusted for sex, age, wealth, 
and country; Model 2 - adjusted for the variables in Model 1 and depression. We also 
constructed models adjusting for depression as a previous World Mental Health Survey study 
[36],  demonstrated that the risk for various chronic conditions is higher in those with 
comorbid depressive–anxiety disorder than depression or anxiety alone. To adjust for 
country, dummy variables for each country were included in the models, following the 
methods used in previous WHS publications [37, 38]. The number of chronic physical 
conditions was included in the models as a categorical variable in this analysis.  
We also conducted country-wise multivariable logistic regression analyses to assess 
the association between the number of chronic physical conditions and anxiety while 
adjusting for sex, age, wealth, and depression. Given that there was a linear increase in the 
odds for anxiety with increasing numbers of chronic physical conditions in the above-
mentioned pooled multivariable analysis, we included the number of chronic physical 
conditions as a continuous variable in the country-wise models. A pooled estimate was 
obtained by combining the estimates for each country into a random-effect meta-analysis. To 
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assess the level of between-country heterogeneity in the association between the number of 
chronic physical conditions and anxiety, the Higgins’ I2  statistic was calculated. This 
represents the degree of heterogeneity that is not explained by sampling error with a value of 
<40% often considered as negligible and 40-60% as moderate heterogeneity [39]. The sample 
weighting and the complex study design were taken into account in all regression analyses as 
well as the calculation of proportions and their 95% CIs. Results from the logistic regression 
models are presented as ORs with 95% CIs. The level of statistical significance was set at 
P<0.05. 
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Results 
The mean age (SD) of the sample was 38.6 (16.1) years and 50.6% were females. The overall 
prevalence of anxiety was 10.3%. The prevalence of chronic physical conditions ranged from 
1.4% (visual impairment) to 15.1% (angina) (Table 1). More than one-third of the sample 
had at least one chronic physical condition and 13.4% had multimorbidity. Female sex, older 
age, lower levels of wealth, depression, all chronic physical conditions, and higher numbers 
of chronic physical conditions were associated with higher prevalence of anxiety. The 
prevalence of anxiety was much higher for all chronic physical conditions compared to the 
overall prevalence (10.3%) with the highest prevalence being observed for visual impairment 
(43.4%), chronic back pain (28.6%), and tuberculosis (24.7%) (Figure 1). There was a linear 
increase in the prevalence of anxiety with increasing numbers of chronic physical conditions 
where this prevalence increased from 13.8% for only one chronic physical condition to 
47.3% with ≥5 conditions. The correlations between the chronic physical conditions are 
shown in Table 2. The strongest correlations were observed for: arthritis and angina or 
chronic back pain; hearing problem and edentulism or visual impairment. The associations 
between chronic physical conditions or their numbers and anxiety estimated by multivariable 
logistic regression are shown in Table 3. In the models unadjusted for depression, the OR of 
the individual chronic physical conditions and the number of them were significant in all 
models with the OR ranging from 1.14 (edentulism) to 4.12 (visual impairment) for the 
individual conditions. After adjustment for depression, the ORs were attenuated but still 
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remained significant for all chronic physical conditions and the number of them with the 
exception of edentulism. The significant ORs for the individual conditions ranged from 1.50 
(hearing problem) to 3.69 (visual impairment), while compared to those with no chronic 
physical condition, there was a linear increase in the ORs associated with increased number 
of conditions: 1 condition (OR=1.94; 95%CI=1.76-2.13), 2 conditions (OR=2.63; 
95%CI=2.34-2.96); 3 conditions (OR=3.56; 95%CI=3.00-4.22); 4 conditions (OR=4.69; 
95%CI=3.64-6.04); and ≥5 conditions (OR=5.49; 95%CI=3.73-8.09). The country-wise 
association between the number of chronic physical conditions and anxiety estimated by 
multivariable logistic regression is shown in Figure 2. The ORs associated with a one-unit 
increase in the number of chronic physical conditions ranged from 1.24 in Ecuador to 2.82 in 
China with the pooled OR (95%CI) estimated by meta-analysis being 1.54 (1.48-1.59). The 
ORs were significant in all countries with the exception of Bosnia-Herzegovina. A moderate 
level of between-country heterogeneity was observed (Higgin’s I2= 42.2). 
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Discussion 
General findings 
To the best of our knowledge, this is the first multinational study to explore associations 
between chronic conditions, multimorbidity and anxiety. While one in ten reported being 
worried or anxious in the past 30 days, more than one-third of the sample had at least one 
chronic physical condition and 13.4% suffered from multimorbidity (i.e. at least 2 chronic 
physical conditions). The findings were consistent across all countries. Our data show that the 
ubiquity of multiple chronic conditions likely compounds the higher odds of anxiety 
symptoms. There was a linear increase in the prevalence of anxiety with increasing numbers 
of chronic physical conditions where the prevalence increased from 13.8% for only one 
chronic physical condition to 47.3% with ≥5 conditions. In the adjusted logistic regression, 
the presence of one physical comorbidity was associated with an almost 2-fold increased 
odds of anxiety symptoms (OR 1.94), rising to an OR of 5.49 in those with 5 or more 
conditions. Our data also show that the prevalence of anxiety is much higher for all chronic 
physical conditions than people without the condition. This finding suggests that anxiety 
symptoms are associated with the dysregulation of multiple physiological systems and is not 
limited to respiratory, cardiovascular, metabolic, and inflammatory systems. The inclusion of 
depression in the models led to an attenuation of the associations for all chronic conditions. 
Higher numbers of chronic conditions were strongly and significantly associated with anxiety 
even after adjustment for depression. 
One should note that our data are cross-sectional and we therefore cannot make 
inference to the directionality of our findings. However, a number of hypotheses have been 
proposed for the increased risk of physical conditions in people with anxiety including 
psychotropic medication use [40], biological risk factors such as an increased inflammatory 
profile, including increased levels of C-reactive protein and interleukin-6 [41] and 
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hypothalamic-pituitary-adrenocortical (HPA) axis dysregulation [42]. Moreover, a stress 
response may contribute to the pathophysiology of both, anxiety and several chronic 
conditions [43]. The heightened presence of anxiety among people with several chronic 
conditions and especially those with multimorbidity may in  turn be related to the associated 
worry of having an illness and be attributed to difficulty adjusting to the burden of the 
illnesses [44]. Alternatively, another possible explanation for the association is that those 
who already have anxiety symptoms may receive more medical diagnoses if these symptoms 
result in patients visiting their doctors more often [25]. Additionally, anxious persons may be 
more attentive of bodily symptoms, thus leading to more diagnoses [25]. Finally, feelings of 
anxiety may also lead to unhealthy behaviors, such as smoking [45], alcohol consumption 
[46], and a sedentary lifestyle [47], which might also be implicated in the development of 
chronic conditions and multimorbidity. 
 
Practical implications 
Given the early onset of anxiety and the similarly early etio-pathogenesis of many 
chronic physical conditions [50], treatment of anxiety should optimally incorporate attention 
to preventing the development of other chronic diseases and multimorbidity by focusing on 
healthy lifestyle behaviors, with a parallel focus on anxiety symptoms emerging early in the 
course of the treatment for chronic physical conditions. Much could be done in primary 
health care settings to optimize chronic disease prevention approaches for those with mental 
health symptoms and a mental health focus in those with chronic conditions. Optimal primary 
prevention of chronic physical conditions among people with anxiety (and vice versa) could 
enhance the quality of life of many people worldwide. 
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Limitations and future research 
As stated, the most important limitation of the current study is its cross-sectional nature 
which limits conclusions about the direction or causal nature of the relationships between the 
presence of anxiety, chronic conditions and multimorbidity. However, although cross-
sectional studies cannot determine whether the associations between anxiety and 
multimorbidity patterns are causal, we observed that a higher prevalence of anxiety was 
associated with a higher number of physical co-morbidities. Longitudinal trajectories may 
however illuminate in more detail the likely multifactorial mechanisms underlying these 
cross-sectional associations. It is for example also possible that anxiety precedes the 
development of chronic conditions and multimorbidity. A second limitation is that the 
anxiety variable used was based on a single question. However, this question has been used 
in previous WHS publications to define anxiety [28, 29]. The assessment of the degree 
anxiety symptoms may have been enhanced by our use of severe and extreme categories. 
However, the specificity and sensitivity of this question against the gold standard diagnosis 
of anxiety disorders is not established.  Therefore, future studies should include a more 
complete anxiety assessment and ideally use a clinical diagnosis. Third, since the information 
on chronic conditions was based on self-report, reporting biases may exist. More in detail, the 
reliance on self-report and not medical records may mean our data are actually 
underestimates.  Despite these limitations, the strengths of the study include the large sample 
size and the multi-national scope, including most regions of the world, but in particular 
understudied LMICs in Africa, Latin-America, Asia and Eastern Europe. 
In conclusion, our study clearly shows that the prevalence of anxiety increases with 
increasing numbers of comorbid chronic physical conditions. We recommend that mental 
health and primary care providers consider screening for the presence of anxiety symptoms 
especially in individuals with multimorbidity.  
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Table 1 Characteristics of the study sample (overall and by the presence of anxiety) 
        Anxiety 
Characteristics   N Overall N No N Yes 
Sex Male 78,783 49.4 72,661 50.7 5,412 37.7 
 
Female 95,806 50.6 84,714 49.3 10,339 62.3 
Age (years) 18-34 73,627 47.5 68,094 49.0 4,878 34.3 
 
35-59 72,791 39.2 65,406 38.5 6,806 44.5 
 
60+ 28,084 13.4 23,803 12.5 4,062 21.2 
Wealth Poorest 39,654 20.1 34,403 19.5 4,566 25.4 
 
Poorer 34,638 20.0 30,584 19.7 3,356 22.2 
 
Middle 31,673 19.9 28,419 20.0 2,620 18.7 
 
Richer 30,243 20.0 27,366 20.2 2,293 18.2 
 
Richest 29,111 20.0 26,508 20.5 1,843 15.5 
Depression No 158,015 93.0 146,570 95.5 10,853 70.3 
 
Yes 10,236 7.0 6,145 4.5 4,062 29.7 
Angina No 146,482 84.9 135,156 86.6 10,774 69.3 
 
Yes 26,035 15.1 21,123 13.4 4,821 30.7 
Arthritis No 146,192 86.2 134,272 87.4 11,364 76.1 
 
Yes 25,021 13.8 20,859 12.6 4,061 23.9 
Asthma No 162,998 94.5 148,371 95.2 14,028 89.0 
 
Yes 8,645 5.5 7,130 4.8 1,482 11.0 
Chronic back pain No 160,233 93.1 146,879 94.5 12,748 80.9 
 
Yes 9,985 6.9 7,336 5.5 2,626 19.1 
Diabetes No 165,074 97.0 150,161 97.4 14,309 93.0 
 
Yes 5,224 3.0 4,251 2.6 948 7.0 
Edentulism No 152,893 94.0 138,942 94.5 13,423 89.7 
 
Yes 11,119 6.0 9,487 5.5 1,587 10.3 
Hearing problem No 165,869 96.5 150,836 96.9 14,388 93.3 
 
Yes 6,159 3.5 4,943 3.1 1,175 6.7 
Tuberculosis No 155,773 98.3 141,893 98.6 13,276 96.0 
 
Yes 2,620 1.7 2,058 1.4 550 4.0 
Visual impairment No 164,051 98.6 149,276 99.1 14,377 94.2 
 
Yes 1,942 1.4 1,212 0.9 724 5.8 
Number of chronic 0 107,183 64.4 101,135 67.3 5,701 37.8 
physical conditions 1 38,258 22.1 33,555 21.2 4,586 30.1 
 
2 14,913 8.8 12,176 7.8 2,690 17.6 
 
3 5,364 3.3 4,039 2.6 1,312 9.1 
 
4 1,638 1.1 1,120 0.8 513 3.8 
  5+ 543 0.4 305 0.2 234 1.6 
Data are unweighted N and weighted percentage. 
The difference in sample characteristics between those with and without anxiety was statistically significant for 
all characteristics (Chi-squared test p<0.001). 
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Table 2 Tetrachoric correlations of physical health conditions among those with anxiety 
          Angina Arthritis Asthma 
Chronic 
back pain 
Diabetes Edentulism 
Hearing 
problem 
Tuberculosis 
Visual 
impairment 
Angina 1 
        
Arthritis 0.30* 1 
       
Asthma 0.24* 0.19* 1 
      
Chronic back pain 0.17* 0.30* 0.14* 1 
     
Diabetes 0.24* 0.23* 0.21* 0.18* 1 
    
Edentulism 0.13* 0.19* 0.17* 0.14* 0.28* 1 
   
Hearing problem 0.16* 0.25* 0.14* 0.17* 0.14* 0.40* 1 
  
Tuberculosis 0.25* 0.19* 0.30* 0.11* 0.12* 0.03 0.09* 1 
 
Visual impairment 0.09* 0.22* 0.16* 0.17* 0.17* 0.20* 0.38* -0.02 1 
* p<0.05 
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Table 3 Associations between chronic physical conditions and number of chronic physical 
conditions and anxiety estimated by multivariable logistic regression 
  Model 1 Model 2 
  OR 95%CI OR 95%CI 
Angina 2.35** [2.16,2.54] 1.97** [1.79,2.16] 
Arthritis 1.74** [1.59,1.90] 1.54** [1.39,1.70] 
Asthma 1.78** [1.57,2.02] 1.56** [1.36,1.79] 
Chronic back pain 2.67** [2.41,2.97] 2.23** [1.99,2.50] 
Diabetes 1.99** [1.69,2.34] 1.83** [1.50,2.22] 
Edentulism 1.14* [1.01,1.29] 1.13 [0.97,1.31] 
Hearing problem 1.63** [1.42,1.87] 1.50** [1.29,1.74] 
Tuberculosis 2.29** [1.84,2.84] 1.85** [1.45,2.35] 
Visual impairment 4.12** [3.36,5.04] 3.69** [2.95,4.62] 
Number of chronic physical conditions 
  
    0 1.00 
 
1.00 
 
    1 2.08** [1.90,2.27] 1.94** [1.76,2.13] 
    2 3.10** [2.79,3.45] 2.63** [2.34,2.96] 
    3 4.54** [3.90,5.30] 3.56** [3.00,4.22] 
    4 6.79** [5.44,8.47] 4.69** [3.64,6.04] 
    5+ 9.66** [6.88,13.57] 5.49** [3.73,8.09] 
Abbreviation: OR odds ratio; CI confidence interval 
Each chronic physical condition or number of chronic physical conditions was included separately in different 
models. 
Model 1: Adjusted for sex, age, wealth, and country. 
Model 2: Adjusted for sex, age, wealth, depression, and country. 
* p<0.05, ** p<0.001 
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Figure 1 Prevalence of anxiety by chronic physical condition and number of chronic physical 
conditions 
 
Estimates are based on weighted sample.  
Bars denote 95% confidence intervals. 
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Figure 2 Country-wise association between the number of chronic physical 
conditions (exposure) and anxiety (outcome) estimated by multivariable logistic 
regression 
 
Abbreviation: OR odds ratio; CI confidence interval 
The variable on chronic physical conditions referred to the number of chronic physical conditions and 
was a continuous variable with values, 0, 1, 2, 3, 4, and 5+. 
The models were adjusted for sex, age, wealth, and depression. 
